Today’s Stock Market in 2-Minutes
April 10, 2026
-
-
Smarter Workforce Platforms Boost Enterprise Value
April 10, 2026
-
Why Lenders Are Lining Up Behind Near-Production Gold
April 10, 2026
-
BiomX Acquires Zorronet, Autonomous AI Command-and-Control Platform for Real-Time Defense and Security Applications
April 10, 2026
-
Top News
- AMTD Provides Updates to Shareholders Regarding Positive Developments on the Expected Closing of Various Transactions Amounting to ~US$328 Million April 10, 2026
- Nightfood Holdings Inc. (OTCQB: NGTF) Brings AI-Enabled Robotics Platform to Growing Pharma Manufacturing Space April 10, 2026
- Oncotelic Therapeutics Inc. (OTCQB: OTLC) Strengthening Position with AI-Driven Tech in Automated Compliance Space April 10, 2026
- OptimumBank Holdings, Inc. Announces Initiation of Coverage by Alliance Global Partners April 10, 2026
Sequire Spotlight Presents: Gevo (GEVO) – Drop-In Jet Fuel From Renewables Poised for Scale
Patrick Gruber, CEO of Gevo (NASDAQ: GEVO), shares how the company is pioneering renewable, drop-in hydrocarbon jet fuels that are cost-competitive with traditional petroleum-based alternatives. With over 450 patents and projects backed by a $1.63B DOE loan guarantee, Gevo is scaling commercial production through facilities in South Dakota and North Dakota. The company’s ethanol-based jet fuel, carbon capture, and RNG assets are unlocking significant revenue streams—positioning Gevo to become EBITDA positive in 2025. With $270M+ in cash, strategic partnerships, and bipartisan support for 45Z tax credits, Gevo is accelerating the transition to net-zero aviation fuels.
May 22, 2025Popular Reads
-
Biofrontera Inc.: A Dermatology Company Scaling with Momentum
April 8, 2026
-
Onconetix Highlights Realbotix’s Launch of Vinci AI Vision System with Delivery of First Vinci-Equipped Humanoid Robot to Ericsson
Vinci Enables Realbotix Robots to Recognize People, Recall Conversations, and Track Engagement; Onconetix Recently Entered into a Definitive Agreement to Acquire Realbotix LLC, a Subsidiary of Realbotix Corp. CINCINNATI, Ohio, April 09, 2026 (GLOBE NEWSWIRE) — Onconetix, Inc. (Nasdaq: ONCO) (“Onconetix” or the “Company”) is providing the following summary of a press release issued by […]
April 9, 2026
-
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Strengthening Position with AI-Driven Tech in Automated Compliance Space
NEW YORK, April 10, 2026 (GLOBE NEWSWIRE) — via AINewsWire — Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by AINewsWire (“AINW”), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. To view the […]
April 10, 2026
-
Jaguar Health Completes Effectiveness Trial to Support FDA Approved Crofelemer for Treatment of Chemotherapy-Induced Diarrhea (CID) in Dogs
April 8, 2026
News
-
Today’s Stock Market in 2-Minutes
April 10, 2026
-
AMTD Provides Updates to Shareholders Regarding Positive Developments on the Expected Closing of Various Transactions Amounting to ~US$328 Million
April 10, 2026
-
Smarter Workforce Platforms Boost Enterprise Value
April 10, 2026
-
Nightfood Holdings Inc. (OTCQB: NGTF) Brings AI-Enabled Robotics Platform to Growing Pharma Manufacturing Space
April 10, 2026
-
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Strengthening Position with AI-Driven Tech in Automated Compliance Space
April 10, 2026
-
OptimumBank Holdings, Inc. Announces Initiation of Coverage by Alliance Global Partners
April 10, 2026
-
NewtekOne, Inc. Pays Off and Expects to Terminate Revolving Lines of Credit at Holding Company Subsidiary
April 10, 2026
-
Annovis Closes $10 Million Offering, Extending Cash Runway Through Phase 3 Alzheimer’s Disease 6-Month NDA Submission
April 10, 2026